|
|
Taiwan Academic Institutional Repository >
Browse by Title
|
Showing items 231186-231235 of 2348617 (46973 Page(s) Totally)
<< < 4619 4620 4621 4622 4623 4624 4625 4626 4627 4628 > >>
View [10|25|50] records per page
| 國立交通大學 |
2014-12-12T02:55:22Z |
BPMN* 與工作流程管理系統之整合
|
羅皓仁; How-Jen Lo; 王豐堅; Feng-Jian Wang |
| 國立臺灣科技大學 |
2008 |
BPMN-based business process model feasibility analysis: A petri net approach
|
Ou-Yang, C.;Lin, Y.D. |
| 國立成功大學 |
2016-08-31 |
BPMN在環境智慧化之應用-以室內舒適度為例
|
洪暎筑; Hong, Ying-Jhu |
| 國立中山大學 |
2008-08-15 |
BPM導入成功模式之個案研究
|
陳文裕 |
| 國立交通大學 |
2014-12-12T01:26:18Z |
BPM系統導入與整合之研究－以A公司為例
|
鄭文量; Cheng, Wen-Liang; 林妙聰; Lin, Bertrand M.T. |
| 中原大學 |
2007-07-07 |
BPM資訊系統實務應用特性之研究
|
李訓仁; Hsun-Jen Lee |
| 中華大學 |
2009 |
BPN for Land Cover Classification by Using Remotely Sensed Data
|
陳莉; Chen, Li |
| 中國文化大學 |
2009-08 |
BPN for Land Cover Classification by Using Remotely Sensed Data
|
Hui-Chung Yeh, Tai-Sheng Wang, Li Chen, Chih-Hung Tan, Yu-Chu Tsai[著] |
| 國立政治大學 |
1996 |
BPN暨RN神經網路與向量誤差修正模型對國內債券價格之預測績效
|
紀如龍; Jih, Ru-Long |
| 淡江大學 |
2007-08 |
BPON、EPON與GPON的傳輸效率差異性評估與分析
|
羅丕丞; 林勤偉; 林其誼; 方偉昌; 王井煦; 鄭石源 |
| 建國科技大學 |
2010 |
BPR+QMS Concept for SME's ERP System Implementation– An Empirical Case in Taiwan
|
廖仁傑 |
| 淡江大學 |
2006-11 |
BPR,TQM 與組織創新-以中國文化大學推廣教育部為例
|
廖述賢 |
| 淡江大學 |
2006-11 |
BPR,TQM與組織創新：以中國文化大學推廣教育部為例
|
廖述賢; 張文榮; 吳啟絹; 陳怡秀 |
| 國家衛生研究院 |
2014-12 |
BPR-3P0128 inhibits RNA-dependent RNA polymerase elongation and VPg uridylylation activities of Enterovirus 71
|
Balaji, VA;Chen, GW;Hsieh, PT;Horng, JT;Hsu, JTA;Hsieh, HP;Chen, TC;Weng, KF;Shih, SR |
| 國家衛生研究院 |
2013-04-07 |
BPR000K, a novel Aurora kinase inhibitor
|
Chao, YS;Hsu, JTA;Chen, CT;Yeh, TK;Pan, SL;Hsieh, HP |
| 國家衛生研究院 |
2011-01 |
BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities
|
Hu, CB;Chen, CP;Yeh, TK;Song, JS;Chang, CY;Chuu, JJ;Tung, FF;Ho, PY;Chen, TW;Lin, CH;Wang, MH;Chang, KY;Huang, CL;Lin, HL;Li, WT;Hwang, DR;Chern, JH;Hwang, LL;Chang, JY;Chao, YS;Chen, CT |
| 國家衛生研究院 |
2022-11-15 |
BPR0C261, an analogous of microtubule disrupting agent D-24851 enhances the radiosensitivity of human non-small cell lung cancer cells via p53-dependent and p53-independent pathways
|
Leu, JD;Lin, ST;Chen, CT;Chang, CA;Lee, YJ |
| 衛生福利部國家中醫藥研究所 |
2013 |
BPR0C305, an orally active microtubule-disrupting anticancer agent
|
Li, Wen-Tai; Yeh, Teng-Kuang; Song, Jen-Shin; Yang, Yung-Ning; Chen, Tung-Wei; Lin, Chi-Hung; Chen, Ching-Ping; Shen, Chien-Chang; Hsieh, Chih-Chien; Lin, Heng-Liang; Chao, Yu-Sheng; Chen, Chiung-Tong |
| 國家衛生研究院 |
2013-11 |
BPR0C305, an orally active microtubule-disrupting anticancer agent
|
Li, WT;Yeh, TK;Song, JS;Yang, YN;Chen, TW;Lin, CH;Chen, CP;Shen, CC;Hsieh, CC;Lin, HL;Chao, YS;Chen, CT |
| 國家衛生研究院 |
2004-07-01 |
BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo
|
Kuo, CC; Hsieh, HP; Pan, WY; Chen, CP; Lion, JP; Lee, SJ; Chang, YL; Chen, LT; Chen, CT; Chang, JY |
| 國家衛生研究院 |
2012-01 |
BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML
|
Lin, WH;Jiaang, WT;Chen, CW;Yen, KJ;Hsieh, SY;Yen, SC;Chen, CP;Chang, KY;Chang, CY;Chang, TY;Huang, YL;Yeh, TK;Chao, YS;Chen, CT;Hsu, JT |
| 國立交通大學 |
2014-12-08T15:22:05Z |
BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML
|
Lin, W-H; Jiaang, W-T; Chen, C-W; Yen, K-J; Hsieh, S-Y; Yen, S-C; Chen, C-P; Chang, K-Y; Chang, C-Y; Chang, T-Y; Huang, Y-L; Yeh, T-K; Chao, Y-S; Chen, C-T; Hsu, J. T-A |
| 國家衛生研究院 |
2012-11 |
BPR1J271, a novel FLT3 inhibitor for treating acute myeloid leukemia
|
Chen, CT;Lin, WH;Chou, LH;Chen, CP;Yen, SC;Huang, YL;Yeh, TK;Hsu, JTA;Jiaang, WI;Chao, YS |
| 國家衛生研究院 |
2018-08-24 |
BPR1J373, a novel multi-targeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor
|
Tsai, HJ;Jiaang, WT;Shih, NY;Fletcher, JA;Lin, MJ;Yang, MY;Chen, CT;Hsu, TJ;Wu, CC;Lin, HY;Chen, LT |
| 國家衛生研究院 |
2018-08-24 |
BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor
|
Tsai, HJ;Jiaang, WT;Shih, NY;Fletcher, JA;Lin, MJ;Yang, MY;Chen, CT;Hsu, TAJ;Wu, CC;Lin, HY;Chen, LT |
| 國立成功大學 |
2018 |
BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor
|
Tsai, H.-J.;Jiaang, W.-T.;Shih, N.-Y.;Fletcher, J.A.;Lin, M.-J.;Yang, M.-Y.;Chen, Chen C.-T.;Hsu, T.-A.J.;Wu, C.-C.;Lin, H.-Y.;Chen, L.-T. |
| 國家衛生研究院 |
2016-10 |
BPR1J373, an oral multiple tyrosine kinase inhibitor, targets c-KIT for the treatment of c-KIT driven myeloid leukemia
|
Chen, LT;Chen, CT;Jiaang, WT;Chen, TY;Butterfield, JH;Shih, NY;Hsu, JT;Lin, HY;Lin, SF;Tsai, HJ |
| 國立成功大學 |
2016-10-01 |
BPR1J373, an Oral Multiple Tyrosine Kinase Inhibitor, Targets c-KIT for the Treatment of c-KIT-Driven Myeloid Leukemia
|
Chen, Li-Tzong; Chen, Chiung-Tong; Jiaang, Weir-Torn; Chen, Tsai-Yun; Butterfield, Joseph H.; Shih, Neng-Yao; Hsu, John Tsu-An; Lin, Hui-You; Lin, Sheng-Fung; Tsai, Hui-Jen |
| 國家衛生研究院 |
2011-08 |
BPR1K653, a novel aurora kinase inhibitor, exhibits potent anti-proliferative activity in MDR1 (P-gp170)-mediated multidrug-resistant cancer cells
|
Cheung, CH;Lin, WH;Hsu, TA;Hour, TC;Yeh, TK;Ko, S;Lien, TW;Coumar, MS;Liu, JF;Lai, WY;Shiao, HY;Lee, TR;Hsieh, HP;Chang, JY |
| 國立成功大學 |
2011-08-24 |
BPR1K653, a Novel Aurora Kinase Inhibitor, Exhibits Potent Anti-Proliferative Activity in MDR1 (P-gp170)-Mediated Multidrug-Resistant Cancer Cells
|
Cheung, Chun Hei Antonio; Lin, Wen-Hsing; Hsu, John Tsu-An; Hour, Tzyh-Chyuan; Yeh, Teng-Kuang; Ko, Shengkai; Lien, Tzu-Wen; Coumar, Mohane Selvaraj; Liu, Jin-Fen; Lai, Wen-Yang; Shiao, Hui-Yi; Lee, Tian-Ren; Hsieh, Hsing-Pang; Chang, Jang-Yang |
| 國家衛生研究院 |
2011-09-23 |
BPR1K653, a novel Aurora Kinase Inhibitor, exhibits potent anti-proliferative activity in P-gp170 (MDR1)-mediated VX680-resistant cancer cells in vitro and in vivo
|
Hsieh, HP;Cheung, CHA;Lin, WH;Hsu, TA;Coumar, MS;Chao, YS;Chang, JY |
| 國家衛生研究院 |
2019-07-03 |
BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine
|
Chao, PK;Chang, HF;Chang, WT;Yeh, TK;Ou, LC;Chuang, JY;Tsu-An Hsu, J;Tao, PL;Loh, HH;Shih, C;Ueng, SH;Yeh, SH |
| 國立成功大學 |
2020 |
BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine
|
Chao, P.-K.;Chang, H.-F.;Chang, W.-T.;Yeh, T.-K.;Ou, L.-C.;Chuang, J.-Y.;Tsu-An, Hsu J.;Tao, P.-L.;Loh, H.H.;Shih, C.;Ueng, S.-H.;Yeh, S.-H. |
| 國家衛生研究院 |
2010-01 |
BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses
|
Shih, SR;Horng, JT;Poon, LL;Chen, TC;Yeh, JY;Hsieh, HP;Tseng, SN;Chiang, C;Li, WL;Chao, YS;Hsu, JT |
| 國立交通大學 |
2014-12-08T15:07:38Z |
BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses
|
Shih, Shin-Ru; Horng, Jim-Tong; Poon, Leo L. M.; Chen, Tzu-Chun; Yeh, Jiann-Yih; Hsieh, Hsing-Pang; Tseng, Sung-Nain; Chiang, Chiayn; Li, Wan-Ling; Chao, Yu-Sheng; Hsu, John T. -A. |
| 國家衛生研究院 |
2015-08 |
BPR2P001S0, a Coumarin derivative, induced cell cycle arrest in A549 through inhibiting PDPK1 activity
|
Lin, PH;Jao, TM;Hung, YL;Hsieh, HP;Yang, YC;Chang, SY |
| 國家衛生研究院 |
2024-04 |
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir
|
Tang, WF;Chang, YH;Lin, CC;Jheng, JR;Hsieh, CF;Chin, YF;Chang, TY;Lee, JC;Liang, PH;Lin, CY;Lin, GH;Cai, JY;Chen, YL;Chen, YS;Tsai, SK;Liu, PC;Yang, CM;Shadbahr, T;Tang, J;Hsu, YL;Huang, CH;Wang, LY;Chen, CC;Kau, JH;Hung, YJ;Lee, HY;Wang, WC;Tsai, HP;Horng, JT |
| 國家衛生研究院 |
2020-08 |
BPR6K609: An Aurora kinase inhibitor targeting small cell lung cancer with MYC amplification
|
Chi, YH;Chang, CP;Ke, YY;Lin, WH;Wang, WP;Tsai, CH;Chen, YT;Su, YJ;Hung, MC;Wu, ZW;Wu, MH;Yeh, TK;Chen, CP;Song, JS;Chen, CT;Shih, C |
| 國家衛生研究院 |
2021-01 |
BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy
|
Chen, YY;Lo, CF;Chiu, TY;Hsu, CY;Yeh, TK;Chen, CP;Huang, CL;Huang, CY;Wang, MH;Huang, YC;Ho, HH;Chao, YS;Shih, JC;Tsou, LK;Chen, CT |
| 國家衛生研究院 |
2019-07 |
BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy
|
Hsu, CY;Chen, YY;Lo, CF;Chiu, TY;Chen, CP;Huang, CL;Huang, CY;Wang, MH;Chao, YS;Shih, JC;Yeh, TK;Tsou, LK;Chen, CT |
| 國立中山大學 |
2012-08-20 |
BPR實施方法論 － 以A個案公司為例
|
吳則蔚 |
| 元智大學 |
1994 |
BPR組織特徵之認知的實證研究
|
陳建志 |
| 國立中山大學 |
2015-07-27 |
BPR結合MDA於外包管理系統開發之研究－以高爾夫球頭製造商為例
|
何佩蓉 |
| 淡江大學 |
1997-05 |
BPS domain wall solutions in self-dual Chern-Simons-Higgs systems
|
Kao, Hsien-Chung; Lee, Kimyeong; Lee, Taejin |
| 臺大學術典藏 |
2019-12-20T01:18:33Z |
BPS states in omega background and integrability
|
Bulycheva, K.;Chen, H.-Y.;Gorsky, A.;Koroteev, P.; Bulycheva, K.; Chen, H.-Y.; Gorsky, A.; Koroteev, P.; HENG-YU CHEN |
| 臺大學術典藏 |
2012 |
BPS states on M5-brane in large C-field background
|
Ho, P.-M.;Ma, C.-T.;Yeh, C.-H.; Ho, P.-M.; Ma, C.-T.; Yeh, C.-H.; PEI-MING HO |
| 中原大學 |
2014-07-28 |
BPSG薄膜特性分析研究與沉積製程優化
|
詹益禎; Yi-Chen Chan |
| 國立臺灣大學 |
1997-07 |
BPSK modulator using VCCS and resonator without carrier signal and balance modulator
|
Chen, Juin-Hung; Tsao, Hen-Wai |
| 臺大學術典藏 |
2018-09-10T06:22:12Z |
BPSK modulator using VCCS and resonator without carrier signal and balance modulator
|
Chen, J.-H.; Tsao, H.-W.; HEN-WAI TSAO |
| 國立臺灣科技大學 |
1999 |
BP神經網路式紋路分類器之設計
|
陳冠翰 |
Showing items 231186-231235 of 2348617 (46973 Page(s) Totally)
<< < 4619 4620 4621 4622 4623 4624 4625 4626 4627 4628 > >>
View [10|25|50] records per page
|
